P-glycoprotein Expression and Drug Resistance in Tumor Cells
Author Information
Author(s): D Nielsen, J Enksen, C Maare, AH Jakobsen, T Skovsgaard
Primary Institution: University of Copenhagen
Hypothesis
Does daunorubicin induce P-glycoprotein expression in Ehrlich ascites tumor cells through mutation or induction?
Conclusion
The study shows that P-glycoprotein expression and daunorubicin resistance are primarily acquired through selection of spontaneously arising mutants.
Supporting Evidence
- 44% of the clones showed significantly increased expression of P-glycoprotein compared to the original cells.
- The mutation rate for drug resistance was estimated at 4.1 x 10^-6 per cell generation.
- Drug resistance varied from 2.5- to 5.2-fold in the surviving clones.
Takeaway
The researchers wanted to see if a drug called daunorubicin could make cancer cells stronger or change them, and they found that it mostly made stronger cells from random changes, not from the drug itself.
Methodology
Fluctuation analysis was used to assess drug resistance and P-glycoprotein expression in Ehrlich ascites tumor cells after exposure to daunorubicin.
Limitations
The study primarily focused on a single cell line and may not generalize to other types of cancer cells.
Participant Demographics
Mice used were first-generation hybrids of female NRMI and male inbred DBA/2 mice.
Statistical Information
P-Value
4.1 x 10^-6
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website